BBHC
NTUS

Brown Brothers Harriman & Co’s Natus Medical Inc NTUS Stock Holding History

Brown Brothers Harriman & Co’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-217
Closed -$9K – 833
2017
Q1 		$9K Hold
217
– – ﹤0.01% 673
2016
Q4 		$8K Hold
217
– – ﹤0.01% 728
2016
Q3 		$9K Hold
217
– – ﹤0.01% 631
2016
Q2 		$8K Buy
+217
New +$7.27K ﹤0.01% 662

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

Brown Brothers Harriman & Co's NTUS Position: Q2 2017 in Review

Brown Brothers Harriman & Co sold out of Natus Medical Inc (NTUS) in Q2 2017, closing a stake of 217 shares — an estimated $9K sold.

Brown Brothers Harriman & Co first reported a position in NTUS in Q2 2016 and held it in 4 quarters. The position peaked at $9K in Q1 2017. 217 funds tracked by Wall St. Rank hold NTUS as of Q2 2017.

  • Brown Brothers Harriman & Co reported no remaining Natus Medical Inc position as of Q2 2017 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 217 Natus Medical Inc shares in Q2 2017, an estimated $9K.
  • Brown Brothers Harriman & Co first reported a position in Natus Medical Inc in Q2 2016 and held it in 4 quarters.
  • Brown Brothers Harriman & Co's Natus Medical Inc position peaked at $9K in Q1 2017.
  • 217 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2017.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2017, filed 14 Aug 2017.